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The dialysis modality mix in China is quite different from
Hong Kong (HK). A recent article [1] about global differ-
ences in dialysis modality mix showed interesting differ-
ences in peritoneal dialysis (PD) prevalence in 36 countries
(reported 2003–05) but omitted China and HK in its report.
The Gross Domestic Product (GDP) per capita on health-
care and the reimbursement rate of renal services were re-
garded as the main determinants of the dialysis modality
mix, although diabetes was associated with signiﬁcantly
less use of PD at Day 91.
Diabetes is a common cause of end-stage kidney
disease (ESKD) in the Orient. It is interesting that HK has a
‘PD ﬁrst’ policy, where 90% of patients are on PD. Yet, in
China, with a population of 1.3 billion, there are approxi-
mately 260 000 people currently on haemodialysis (HD),
and only 40 000 people on PD. It is estimated that cur-
rently, another one to two million people in China with
ESKD are not receiving dialysis therapy. HK and China are
only separated by a short distance; but how different is
the dialysis provision! Can this be explained by different
macroeconomics and/or renal service indicators? HK spent
∼5% of its GDP on health compared with 10% in the UK,
and 18% in the USA.
In HK, PD is mainly provided by the public health auth-
ority for a nominal charge. The cost of PD was 40% of HD,
but only the basic or glucose-based solution is used. Gov-
ernment funding for HD slots is limited. Patients who do
not have medical contraindications for PD but choose HD
treatment, need to pay for the HD treatment in private
hospitals or charity-subsidized HD units.
What about China? Even though most hospitals are
public hospitals, they receive no subsidy from the govern-
ment, so the focus of any hospital is revenue generation.
In most Chinese cities, the charges of HD are covered by
‘social insurance’ which the patients have paid into, but
there is a co-payment payable by the patient. The
minimum co-payment is 10%, but is variable depending
on the employment of the individual and the place of resi-
dence; some people in the rural areas might have no cov-
erage and need to pay the full treatment cost. The low PD
percentage is largely due to the perceived disadvantage
related to the reimbursement for PD compared with HD,
and the inexpensive cost of nursing for HD.
In China, the Price Bureau under the State Planning and
Development Commission, sets the price of most treat-
ment cost in order to ensure fair pricing. In the case of PD
therapy, there is a charge in relation to PD catheter inser-
tion but there is no charging mechanism or emphasis in
connection with pre-dialysis education or on-going train-
ing and support necessary to maintain the technique or to
prevent complications. Yet, in order for a Chinese hospital
to provide PD service, there are many prerequisite rules
about the PD centre and the staff, presumably with the
objective of protecting patients from poor practice. Not
surprisingly, many renal centres are busy expanding their
HD units, with many hospitals having plans for over 100
HD stations, PD is ascribed a low priority.
In the UK, the cost of home-based PD is cheaper than
in-centre HD by up to a third, and this is the same in
China. In the USA, the prevalence of PD dropped to 7%,
but with a more proﬁtable arrangement with insurance
providers, the PD prevalence has increased to 11%. Like
the USA, many staff in the county hospitals in China lack
PD training and expertise. This leads to poor outcomes
and in turn, failure to offer PD. Still, effort is being made to
provide training for free in some established renal centres.
With 1.5 million Chinese suffering from ESKD, expansion
of PD provision should provide more patients with afford-
able renal replacement therapy. The building of a good
infrastructure for PD is important. There is a need to
educate both staff and patients about dialysis options and
practice. The Chinese nephrology community should act
as the patients’ advocate to ensure PD service receives a
‘fair’ treatment and not hard-done. On a positive note,
because carer's wage is low in China, the families of some
elderly patients could afford assisted PD by hiring carers to
do so.
What then is the right balance of HD and could ‘PD ﬁrst’
policy be successful in other countries as well? The rela-
tively small body size of the Oriental populations, many of
them weighing 50–60 kg, makes three PD exchanges a
day a feasible regimen to provide adequate dialysis. None-
theless, some PD patients are underdialysed or overhy-
drated and would beneﬁt from switching to HD, but under
the present circumstances in HK, would need to wait for a
HD slot.
Only 20 years ago in the UK, there was a huge problem
with HD slots. Up to 50% of the patients in the Northwest
were on PD, and there was no alternative choice for most of
the new patients but to do PD ﬁrst. But as the economy im-
proved, there were more satellite HD units and the percen-
tage of patients on PD started to shrink; the prevalence of
PD in many inner cities has fallen to 20%. The fact that
European patients are larger and there is an ageing popu-
lation might play a role in this but it mainly comes down
to the patient’s choice. But with what and how we provide
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pre-dialysis education are vital. We should always be
mindful that we act in the best interest of patients and also
try not to be wasteful. As there is no difference in survival
outcome between PD and HD, it seems to be appropriate to
recommend a patient to do PD ﬁrst, and change to HD later.
As nephrologists, we would like to extend life with rea-
sonable quality. Preventing harm and secondary prevention
of complications is like planting seeds; the reward is in the
future. In the UK, there is a trend that the dialysis growth is
starting to plateau. This followed the introduction of esti-
mated glomerular ﬁltration rate in 2008 as part of the
routine urea and electrolyte reporting, many UK doctors
became more aware of chronic kidney disease, its preven-
tion and treatment; and, there has been a strong infrastruc-
ture in place for renal conservative management.
In China, nephrologists are championing for reducing
salt intake, controlling hypertension and measuring
urinary microalbumin as the ﬁrst steps to reduce hyper-
tensive kidney disease. There is recognition of the need for
expanding primary-care personnel and community health
centres, and promoting self-care would hopefully stop the
ESKD epidemic in the Orient.
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